Related Experiment Video

Updated: Aug 23, 2026

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
07:44

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Published on: February 17, 2023

[Inhibitory effect of tumor suppressor PTEN on cell growth of endometrial carcinoma]

Xiao-yun Wan1, Yi-fu Shi, Juan-qing Li

  • 1Woman's Hospital, Zhejiang University, Hangzhou 310006, China. xiaoyunw@yahoo.com

Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|August 18, 2004
PubMed
Abstract

Insights

Introducing the phosphatase and tensin homolog (PTEN) gene into endometrial carcinoma cells suppressed their growth. This suggests PTEN could be a potential therapeutic agent for treating this cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Endometrial carcinoma is a prevalent gynecologic malignancy.
  • The phosphatase and tensin homolog (PTEN) is a critical tumor suppressor gene.
  • Dysregulation of PTEN is implicated in various cancers, including endometrial carcinoma.

Purpose of the Study:

  • To investigate the inhibitory effect of the tumor suppressor PTEN on the cell growth of endometrial carcinoma.
  • To assess the feasibility of using adenovirus-mediated gene transfer for PTEN delivery.

Main Methods:

  • Exogenous wild-type PTEN cDNA was delivered into Ishikawa endometrial carcinoma cells using an adenoviral vector (Ad-PTEN).
  • PTEN protein expression was confirmed via Western blot.
  • Cell proliferation was quantified using trypan blue exclusion and MTT assays.

Main Results:

  • Adenovirus-mediated PTEN expression was successfully induced and sustained in Ishikawa cells.
  • PTEN expression significantly inhibited the proliferation of endometrial carcinoma cells.
  • PTEN also suppressed IGF-II-induced proliferation in these cells.

Conclusions:

  • Adenovirus-mediated delivery of PTEN effectively suppresses the growth of human endometrial carcinoma cells.
  • The PTEN gene holds promise as a novel therapeutic agent for endometrial carcinoma.
  • Further research into PTEN-based therapies for endometrial cancer is warranted.

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...